Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AID System Safety and Functionality in T1DM Meal Challenges
NCT03848767Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2019
- Primary completion
- Apr 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Eli Lilly and Company. Primary endpoints: Number of Adverse Events (AEs) at 3 days and Continuous Glucose Monitor (CGM) Measured Percentage of Time <70 mg/dL at 3 days. Started Feb 2019; status: completed.
Beyond the preview
Go deeper on NCT03848767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03848767.